Tumor Necrosis Factor Inhibitor Use Increases Birthweight in Pregnant Women With Rheumatoid Arthritis Independently of the Soluble Fms-Like Tyrosine Kinase-1/Placental Growth Factor Ratio.
Cornelia H QuaakAnna C M KluiversSara J BaartHieronymus T W SmeeleRugina I NeumanLangeza SalehWilly VisserAlexander H J DanserRadboud J E M DolhainPublished in: Journal of the American Heart Association (2024)
http://clinicaltrials.gov. Unique identifier: NCT01345071.